StockData
ADMA Biologics, Inc. logo

ADMA Biologics, Inc. (ADMA) bonds

ADMANasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 17/3029% below fair value
$13.63+0.16 (+1.19%)

Close on Nov 17, 2026Market cap $3.05BP/E 19.5Yield –

Debt

Borrowings on the balance sheet, Jun 30, 2026

Total debt
$196.59M
$3.75M due within a year
Net debt
$60.57M
After $136.02M of cash
Implied interest rate
9.84%
FY2025 interest ÷ average debt
Interest coverage
26.9×
FY2025 operating income ÷ interest

Total debt by fiscal year

Long-term plus current debt, USD

Notes and loans outstanding

As tagged in ADMA Biologics's 10-K for the period ended Dec 31, 2025

ADMA Biologics's filings do not break debt down by note

The debt footnote in the annual report has no machine-readable detail for individual notes, so coupons and maturities cannot be listed.

Credit facilities

Revolving credit lines and other committed borrowing capacity

FacilitySizeDrawn
JPM Term Loan–$74.06M

See a number that looks wrong?